-
Maunank Shah, MD
- Professor of Medicine
Expertise: Infectious Diseases
Research Interests: Domestic TB, HIV transmission, mHealth interventions, Teaching and mentorship, Tuberculosis (TB) diagnostics
-
Paul G. Auwaerter, MD MBA
- Clinical Director, Division of Infectious Diseases
- Professor of Medicine
Expertise: Infectious Diseases
Research Interests: Point of Care Information Technology, Tick borne diseases
-
Karen C. Carroll
- Director, Division Medical Microbiology
- Professor Emerita of Pathology
Expertise: Pathology
Research Interests: Evaluation of novel diagnostic platforms and epidemiology of healthcare associated infections and bloodstream infections.
Research Publications
-
Richard E. Chaisson, MD
- Director, Center for Tuberculosis Research
- Professor of Medicine
Expertise: Infectious Diseases
Research Publications
-
Sara Cosgrove, MD
- Director, Johns Hopkins Hospital Department of Antimicrobial Stewardship
- Professor of Medicine
Expertise: Infectious Diseases
Research Interests: Development of tools and programs to promote rational use of antimicrobials, Epidemiology and management of S. aureus bacteremia, Epidemiology and outcomes of antimicrobial resistance, Prevention of hospital-acquired infections
Research Publications
-
Christine Durand, MD
- Associate Professor of Medicine
Expertise: Infectious Diseases
Research Interests: Organ transplantation in persons living with HIV and hepatitis C
-
Kelly Gebo, MD MPH
- Professor of Medicine
Expertise: Infectious Diseases
Research Interests: <p>Health care utilization, Clinical outcomes research, HIV, COVID, Long COVID, mpox, quality improvement, health care policy</p>
Research Publications
-
Khalil G. Ghanem, MD
- Deputy Director of Education, Department of Medicine, Johns Hopkins Bayview Medical Center
- Professor of Medicine
Expertise: Infectious Diseases
Research Publications
-
Matthew Hamill, MBCHB PhD MPH
- Associate Professor of Medicine
Expertise: Infectious Diseases
Research Interests: <p>HIV/AIDS, POC technology, PrEP/PEP, sexually transmitted infections, Sub Saharan Africa</p>
Research Publications
-
Andrew Karaba, MD PhD
- Assistant Professor of Medicine
Expertise: Infectious Diseases
Research Publications
-
Olivia Saturno Kates, MD MA
- Assistant Professor of Medicine
Expertise: Infectious Diseases
Research Interests: Ethical issues in infectious diseases and transplantation, vaccination policies
-
Morgan Katz, MD MHS
- Associate Professor of Medicine
Expertise: Infectious Diseases
Research Interests: Hospital epidemiology, Infection control
-
Christopher Lippincott, MD MPH
- Clinical Director, Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis
- Assistant Professor of Medicine
Expertise: Infectious Diseases
-
Yuka C. Manabe, MD
- Associate Director of Global Health Research and Innovation
- Professor of Medicine
Expertise: Infectious Diseases
-
Eric Nuermberger, MD
- Professor of Medicine
Expertise: Infectious Diseases
Research Interests: Drug development for tuberculosis and non-tuberculous mycobacterial infections, including Mycobacterium ulcerans disease (Buruli ulcer)
Research Publications
-
Shmuel Shoham, MD
- Professor of Clinical Medicine
Expertise: Infectious Diseases
Research Interests: antibiotic resistant infections in immunocompromised patients, invasive fungal infections, respiratory viral infections in immunocompromised patients
-
Pranita Tamma, MD MPH
- Associate Professor of Pediatrics
Expertise: Pediatric Infectious Diseases
Research Interests: Diagnosing and treating multidrug-resistant infections, improving antibiotic use among children and adults
Research Publications
-
Susan Tuddenham, MD MPH
- Associate Professor of Medicine
Expertise: Infectious Diseases
Research Interests: Sexually transmitted diseases
-
Ethel Weld, MD PhD
- Associate Professor of Medicine
Expertise: Infectious Diseases, Hospital Medicine
Frontiers in Clinical Infectious Diseases (With CME)
In-person
June 5-6, 2025
Johns Hopkins University Bloomberg Center
555 Pennsylvania Avenue, NW
Washington, DC 20001
This activity has been approved for AMA PRA Category 1 Credits™.
Course Description
Infectious diseases remain a dynamic and fascinating field replete with new challenges facing outpatient primary care providers and hospital medicine practitioners alike. This program is designed to explore major infectious diseases topics of particular relevance.
Who Should Attend
This activity is intended for physicians, physician assistants, nurse practitioners, nurses, advanced practice providers, and allied health professionals in the fields of emergency medicine, family practice, infectious diseases, internal medicine, and public health.
Objectives
After participating in this activity, the learner will demonstrate the ability to:
- List new guidelines and emerging approaches for the management of drug-resistant gram negative and gram positive pathogens.
- Describe new strategies and emerging concepts in antibiotic stewardship, antibiotic allergies, and pharmacology of antibiotics.
- Recall new approaches to sexually transmitted infections including prevention, application of emerging diagnostics, and management.
- Discuss new developments in the diagnosis and management and public health approaches to tuberculosis and non-tuberculous mycobacteria.
- Express comprehensive knowledge of emerging concepts in HIV medicine including the usage of long-acting injectables, management of weight gain and metabolic disease.
Accreditation
-
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
-
The Johns Hopkins University School of Medicine designates enduring material for a maximum of 13.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
-
It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies in place to identify and mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.
-
American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) Program
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. -
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
PAs may claim a maximum of 13.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
The Johns Hopkins University has approved this activity for 13.75 contact hours for non-physicians.
Location
Johns Hopkins University Bloomberg Center
at 555 Pennsylvania Avenue NW
555 Pennsylvania Avenue, NW
Washington, DC 20005
https://washingtondc.jhu.edu/bloomberg-center/
Building on Johns Hopkins’ history as the nation’s first research university, the Hopkins Bloomberg Center will serve as a nexus for trusted academic experts, global leaders, policymakers, and students to provide multidisciplinary expertise and objectivity to decision-makers while educating future civic leaders.The Hopkins Bloomberg Center pairs the power of nearly 150 years of research leadership with a deep commitment to democracy and government innovation in a vibrant new convening space. The majestic building features modern, configurable spaces that will heighten collaboration between trusted academic experts, global leaders and policymakers, and the next generation of innovators and leaders. Johns Hopkins is smoke-free. Parking is available nearby, we recommend using SpotHero to reserve parking in advance.
Map/Directions: https://washingtondc.jhu.edu/about/maps-directions/
day oneCurriculum: Thursday, June 5, 2025
Registration & Continental Breakfast
8:45 am – 9:00 am
Welcome & Conference Goals
Maunank Shah, MD, PhD, Course Director and Professor of Medicine, Johns Hopkins University
-
9:00 am – 9:30 am: IDSA Guidelines on Treatment of AMR GN Infections
Pranita Tamma, MD, MPH
9:30 am – 10:00 am: Update on Staph aureus Bacteremia & Oral Therapy
Sara Cosgrove, MD
10:00 am – 10:30 am: Update on Lyme & Tick-borne Infections
Paul Auwaerter, MD, MBA
10:30 am – 10:45 am: Break
10:45 am -11:15 am: Antibiotic Allergies
Santiago Alvarez Arango, MD
11:15 am – 11:45 am: PK/PD Considerations in Management of Infectious Diseases: What’s Hot
Kate Dzintars, PharmD
11:45 am – 12:15 pm: Antibiotic Stewardship in the Elderly
Morgan Katz, MD12:15 pm – 1:15 pm: Lunch
-
1:15 pm – 1:45 pm: HIV Cure
Janet Siliciano, PhD
1:45 pm – 2:15 pm: HIV & LAI
Ethel Weld, MD, PhD
2:15 pm – 2:45 pm: HIV & Weight Gain and Metabolic Disease
Todd Brown, MD, PhD
2:45 pm – 3:15 pm: Point-of-care STI Diagnostics
Yukari Manabe, MD
3:15 pm – 3:45 pm: Break -
3:45 pm – 4:15 pm: Update on Microbiological Approaches to Diagnosis & Drug-resistance Testing
Karen Carroll, MD4:15 pm – 4:45 pm: Mpox
Kelly Gebo, MD4:45 pm – 5:15 pm: Closing Plenary
5:15 pm: Reception
day twoCurriculum: Friday, June 6, 2025
8:00 am – 8:30 am: Registration & Continental Breakfast
8:30 am – 9:00 am: Welcome & Conference Goals
Maunank Shah, MD, PhD, Course Director, Professor of Medicine, Johns Hopkins School of Medicine
-
9:00 am – 9:30 am: Fungal Infections & Their Treatment
Shmuel Shoham, MD
9:30 am – 10:00 am: HIV & Transplant
Christine Durand, MD
10:00 am – 10:30 am: Xeno Transplantation
Olivia Kates, MD, MA10:30 am -10:45 am: Break
-
10:45 am – 11:15 am: What’s New in Herpesviruses
Andrew Karaba, MD, PhD
11:15 am – 11:45 am: New Approaches to Prevention: Updates on Doxycycline PrEP & LAI-LEN
Matthew Hamill, MBChB, PhD, MPH, MSc
11:45 am – 12:15 pm: M. genitalium
Sue Tuddenham, MD, MPH
12:15 pm – 12:45 pm: Challenges when Managing Syphilis
Khalil Ghanem, MD, PhD
12:45 pm – 1:45 pm: Lunch -
1:45 pm – 2:15 pm: New Approaches to NTM: Inhaled Amikacin, Omadacycline, Clofazine, Carbapenem
Christopher Lippincott, MD, MPH2:15 pm – 3:00 pm: TB Chemotherapeutics Update
Eric Nuermberger, MD3:00 pm – 3:15 pm: Break
3:15 pm – 3:45 pm: New Guidelines on Usage of Isolation for TB in Community Settings
Maunank Shah, MD, PhD3:45 pm – 4:15 pm: TB & Comorbidities
Jonathan Golub, PhD, MPH4:15 pm – 5:00 pm: New Approaches to TB Prevention & Control
Richard Chaisson, MD
Johns Hopkins Infectious Diseases Faculty Speakers
Activity Director: Maunank Shah, MD, PhD, Professor of Medicine
Guest Faculty Speakers
Santiago Alvarez Arango, MD
Kate Dzintars, PharmD, BCPS AQ-ID
Fees & CME
Registration Cut-Off Date: May 31, 2025 | 5:00 PM EST
-
Symposium Only: $550.00
Live Bundle: $1,500.00
Methods of Payment: Learners must register and submit full payment prior to the start of the activity. Registration is available through the Office of Online Education. The registration fee includes access to the online modules and in-person attendance at the live activity. Instructional materials, continental breakfasts, refreshment breaks, and lunches will be provided during the in-person activity.
You will receive a confirmation by e-mail from the Office of Online Education. If you have not received it by May 29, 2025, email JHOnline@jhmi.edu to confirm that you are registered. A transcript of attendance will be available upon attestation of your credit hours and submission of the post activity online evaluation.
The Johns Hopkins University reserves the right to cancel or postpone any activity due to unforeseen circumstances. In this event, the University will refund the registration fee but is not responsible for travel expenses. Additionally, we reserve the right to change the venue to a comparable venue. Under such circumstances registrants will be notified as soon as possible. -
A handling fee of $50 will be deducted for cancellation.
-
The syllabus will be accessible online and via your mobile device in the CloudCME App prior to the activity.
-
Post activity, an online evaluation will be available to attendees to evaluate the activity and individual presentations and to identify future educational needs. Upon completion of the evaluation, the learner must attest to the number of hours in attendance. Credits earned will be added to the learner’s transcript and immediately available for print. The last day to access the evaluation and attest to your credits is July 21, 2025.
An outcome survey will be sent to all physician attendees within two months post activity to assist us in determining what impact this activity had on the learner’s practice.
Policies
-
The Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) is committed to protecting the privacy of its members and customers. If you choose to provide us with personal information by sending an email, or by filling out a form with your personal information and submitting it through our Web site, we use that information to respond to your message and to help us provide you with information, products, or services that you request. We do not give, share, sell, or transfer any personal information to a third party unless required by law. The complete University privacy policy may be accessed via the OCME Web site.
-
The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity
-
All rights reserved – The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.
-
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information and safety profile of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.
-
I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
I understand that while I am participating in this capacity, I may be exposed to “protected health information,” as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the “Privacy Regulations”). Protected health information is information about a person’s health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.
I understand that I may direct to the Johns Hopkins Privacy Office any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Office, telephone: 410-614-9900, e-mail: HIPAA@jhmi.edu
Course Requirements
-
There are no prerequisites to participate in this activity.
-
The course will take place on the Canvas LMS (Canvas.jhu.edu). You will need the ability to log on to the platform, preferably using Google Chrome, to complete the content, which will include videos, readings, and assignments. You may also need to take part in other activities on Canvas.jhu.edu.
Hardware requirements: computer; webcam; microphone and speakers or headset.
Software requirements: Google Chrome web browser; access to Canvas.jhu.edu; Zoom web conferencing; Microsoft Office or similar; email. -
Post activity, an online evaluation form will be available to attendees to evaluate the activity and identify future educational needs. Upon completion of the evaluation, the learner must attest to the number of hours in attendance. A certificate of attendance will be available immediately for download or print. The last day to evaluate the material and attest to your credits is May 15, 2028.
-
A post-test will be conducted at the conclusion of the activity. A grade of at least 70% within three attempts is needed to receive CME credit.
-
The Johns Hopkins School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.
-
E-mail the Office of CME: cmenet@jhmi.edu
For general information, please visit the activity webpage at
https://hopkinscme.cloud-cme.com/aph.aspx?P=5&EID=59126
Johns Hopkins Department of Medicine, Division of Infectious Diseases: https://www.hopkinsmedicine.org/infectious-diseases
To participate in additional CME activities presented by the Johns Hopkins School of Medicine Continuing Medical Education Office, please visit https://hopkinscme.cloud-cme.com
Follow the Johns Hopkins School of Medicine Continuing Medical Education Office on Twitter: http://twitter.com/HopkinsCME
Follow the Johns Hopkins School of Medicine Continuing Medical Education Office on Facebook: http://www.facebook.com/HopkinsCME
Check out the CME mobile app CloudCME.
Organization Code: HopkinsCME
For technical assistance with website, CloudCME or credits, please visit our tech support help page: https://hopkinscme.cloud-cme.com/about/help -
The Johns Hopkins School of Medicine did not solicit or receive commercial funding from any ineligible companies, including pharmaceutical and medical device manufacturers, for this activity.